Intrexon has filed for an IPO, an initial public offering, hoping to take company from private to public.
Intrexon with other companies in medicine, animal science, and agriculture to engineer biological products and processes.
The goal is to raise a maximum of $125 million in the offering. Though, we're told it's a figure that could change.
In 2011, the firm had revenue of $5.7 and increased to $13.9 million by 2012.
The group also raised $150 million from financial backers bringing total venture capital to $509 million.
Blacksburg financial advisor Nick Flaherty says applying for an IPO means a company wants to generate money and growth with the end goal of hoping to expand.
He says companies have seen ups and downs from this type of financial move.
"It can be good for the community. When Google became public 9 years ago, the share price were around $100 a share and now it's approaching $900 a share, but there's also been bad ones. Facebook a year and a half ago came out 30 share and immediately dropped to $18," financial advisor, Nick Flaherty says.
The potential for growth with the company becoming public could have great impact on our local economy.